Fibrogen Inc (FGEN)

Jan 06, 2025

Perspective Therapeutics Appoints FibroGen Veteran Juan Graham as New CFO to Drive Growth Strategy - StockTitan

Jan 06, 2025

Jan 05, 2025

State Street Corp Lowers Holdings in FibroGen, Inc. (NASDAQ:FGEN) - Defense World

Jan 05, 2025

Jan 02, 2025

Cue Biopharma (NASDAQ:CUE) versus FibroGen (NASDAQ:FGEN) Head-To-Head Comparison - Defense World

Jan 02, 2025

Jan 01, 2025

FibroGen (NASDAQ:FGEN) Coverage Initiated by Analysts at StockNews.com - Defense World

Jan 01, 2025

Jan 01, 2025

FibroGen (NASDAQ:FGEN) Coverage Initiated at StockNews.com - MarketBeat

Jan 01, 2025

Dec 30, 2024

Court of Chancery Applies Well-Settled Principles To Dismiss Malone/Caremark ‘Hybrid’ Claims - Skadden, Arps, Slate, Meagher & Flom LLP

Dec 30, 2024

Dec 25, 2024

There's No Escaping FibroGen, Inc.'s (NASDAQ:FGEN) Muted Revenues Despite A 26% Share Price Rise - Simply Wall St

Dec 25, 2024

Dec 24, 2024

FibroGen (NASDAQ:FGEN) Now Covered by Analysts at StockNews.com - Defense World

Dec 24, 2024

Dec 24, 2024

Recent Investment Analysts’ Ratings Updates for FibroGen (FGEN) - Defense World

Dec 24, 2024

Dec 23, 2024

Fmr LLC Boosts Holdings in FibroGen, Inc. (NASDAQ:FGEN) - Defense World

Dec 23, 2024

Dec 20, 2024

HC Wainwright Comments on FibroGen FY2024 Earnings - Defense World

Dec 20, 2024

Dec 19, 2024

HC Wainwright Upgrades FibroGen (NASDAQ:FGEN) to Strong-Buy - Defense World

Dec 19, 2024

Dec 19, 2024

HC Wainwright Estimates FibroGen FY2026 Earnings - Defense World

Dec 19, 2024

Dec 18, 2024

FibroGen started at buy by H.C. Wainwright (FGEN:NASDAQ) - Seeking Alpha

Dec 18, 2024

Dec 17, 2024

FibroGen shares rating initiated with Buy on product potential By Investing.com - Investing.com Canada

Dec 17, 2024

Dec 17, 2024

FibroGen shares rating initiated with Buy on product potential - Investing.com

Dec 17, 2024

Dec 17, 2024

FibroGen appoints David DeLucia CFO - MSN

Dec 17, 2024

Dec 17, 2024

FibroGen names David DeLucia as new CFO By Investing.com - Investing.com Canada

Dec 17, 2024

Dec 16, 2024

FibroGen Appoints David DeLucia as CFO - TipRanks

Dec 16, 2024

Dec 16, 2024

FibroGen, Inc. Appoints David DeLucia as Chief Financial Officer - Marketscreener.com

Dec 16, 2024

Dec 16, 2024

FibroGen names David DeLucia as new CFO - Investing.com

Dec 16, 2024

Dec 16, 2024

FibroGen Appoints David DeLucia as Chief Financial Officer - GlobeNewswire

Dec 16, 2024

Dec 16, 2024

FibroGen Names David DeLucia as New CFO to Lead Financial Strategy and Drug Development Push - StockTitan

Dec 16, 2024

Dec 16, 2024

FibroGen (NASDAQ:FGEN) Now Covered by StockNews.com - Defense World

Dec 16, 2024

Dec 12, 2024

Analyzing Unicycive Therapeutics (NASDAQ:UNCY) and FibroGen (NASDAQ:FGEN) - Defense World

Dec 12, 2024

Nov 28, 2024

FibroGen Inc earnings beat by $0.14, revenue topped estimates - Investing.com Nigeria

Nov 28, 2024

Nov 25, 2024

Idiopathic Pulmonary Fibrosis Market Report 2034, by DelveInsight | Companies: FibroGen, Hoffmann-La Roche Ltd, United Therapeutics, Boehringer Ingelheim, Pliant Therapeutics, Inc., Galecto Biotech - The Globe and Mail

Nov 25, 2024

Nov 16, 2024

StockNews.com Begins Coverage on FibroGen (NASDAQ:FGEN) - Defense World

Nov 16, 2024

Nov 15, 2024

ARMISTICE CAPITAL, LLC Reduces Stake in FibroGen Inc - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

FibroGen Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 15, 2024

Nov 14, 2024

FGEN stock touches 52-week low at $0.19 amid market challenges - Investing.com India

Nov 14, 2024

Nov 13, 2024

FibroGen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024

Nov 13, 2024

FibroGen, Inc. (NASDAQ:FGEN) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024

Nov 13, 2024

Earnings call: FibroGen reports strong Q3 sales, advances in oncology pipeline - Investing.com UK

Nov 13, 2024

Nov 13, 2024

FibroGen: Q3 Earnings Snapshot - mySA

Nov 13, 2024

Nov 13, 2024

FibroGen Inc (FGEN) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

FibroGen (FGEN) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 13, 2024

Nov 13, 2024

FibroGen Inc (FGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Cost Reductions By GuruFocus - Investing.com Canada

Nov 13, 2024

Nov 13, 2024

FibroGen Inc (FGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Cost Reductions - Yahoo Finance

Nov 13, 2024

Nov 12, 2024

FibroGen Reports Strong Q3 Growth and Future Plans - TipRanks

Nov 12, 2024

Nov 12, 2024

FibroGen Inc (FGEN) Q3 2024 Earnings: Revenue Surges to $46.3M, EPS at $(0.17), Exceeding Estimates - GuruFocus.com

Nov 12, 2024

Nov 12, 2024

FibroGen Reports Third Quarter 2024 Financial Results - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

FibroGen Q3 Revenue Surges 15% as China Sales Soar; Narrows Net Loss by 73% | FGEN Stock News - StockTitan

Nov 12, 2024

Nov 07, 2024

FibroGen Inc (FGEN) Is On The Launchpad, Waiting For Long-Term Buyers. - Stocks Register

Nov 07, 2024